The Latest Cardiac and Vascular News
– Enhances penetration into the large and growing interventional cardiology and electrophysiology markets – Offers products with demonstrated and differentiated clinical benefits – Expected to be accretive to revenue growth, gross margins and adjusted gross margins while providing attractive financial returns – Purchase price of up to $510 million cash BOSTON, Jan. 20, 2021 /PRNewswire/ — Haemonetics Corporation […]
SANTA CLARA, Calif.–(BUSINESS WIRE)–Cardiva Medical, Inc., an innovator in the field of vascular closure, today announced the appointment of medical device expert Jeryl (“Jeri”) Hilleman to the company’s Board of Directors. “We are thrilled to welcome Jeri to our team and look forward to leveraging her deep expertise with high-growth medical device companies and in […]
SANTA CLARA, Calif.–(BUSINESS WIRE)–Cardiva Medical, Inc., an innovator in the field of vascular closure, today announced that the company has received PMA approval from the U.S. Food and Drug Administration (FDA) for the VASCADE® MVP Venous Vascular Closure System. VASCADE MVP is the first and only vascular closure system designed and labeled specifically for multi-site […]
SANTA CLARA, Calif. & CHICAGO–(BUSINESS WIRE)–Cardiva Medical, Inc., an innovator in the field of vascular closure, today announced that VASCADE® MVP, the first vascular closure system designed specifically for multi-access venous closure following electrophysiology procedures such as arrhythmia ablation, met its endpoints compared to manual compression in a pivotal clinical study. The AMBULATE study is […]
SANTA CLARA, Calif.–(BUSINESS WIRE)–Cardiva Medical, Inc., an innovator in the field of vascular closure, today announced that new data from the randomized AMBULATE study will be presented in a late-breaking session on new trials in cardiovascular care at Scientific Sessions 2018, the annual medical meeting of the American Heart Association (AHA) in Chicago. AMBULATE is […]
SANTA CLARA, Calif.–(BUSINESS WIRE)–Cardiva Medical, Inc., an innovator in the field of vascular closure, today announced the completion of the AMBULATE pivotal trial, one of several clinical trials in the company’s AMBULATE series that are studying the VASCADE MVP Venous Vascular Closure System for use in the closure of mid-bore (6-12 Fr inner diameter sheath) […]
New Vascular Closure Device for Multi-Access Mid-Bore Vein Procedures, Specifically Cardiac Ablation, Aims to Reduce Time to Ambulation and Improve the Patient Experience SANTA CLARA, Calif.–(BUSINESS WIRE)– Cardiva Medical ®, an innovator in the field of vascular closure, today announced that the company has closed on $11 million in additional financing – bringing total equity and debt […]
Cardiva Medical Raises $30 Million – >Financing to Fuel Commercial Growth of VASCADE Vascular Closure System and Development of Next Generation Products for Vascular Closure SANTA CLARA, Calif., March 14, 2017 /PRNewswire/ — Cardiva Medical, an innovator in the field of vascular closure, today announced that the company has completed closing of a $30 million […]
